DS-1, a Modified Quillaja Saponin, Enhances Ocular and Nasal Absorption of Insulin
- 1 November 1995
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 84 (11), 1276-1279
- https://doi.org/10.1002/jps.2600841104
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Insulin delivery in nosedrops: new formulations containing alkylglycosides.Endocrinology, 1994
- Efficacy of Insulin EyedropsJournal of Ocular Pharmacology and Therapeutics, 1994
- Chitosan as a Novel Nasal Delivery System for Peptide DrugsPharmaceutical Research, 1994
- Glucagon Administration to the Rat via Eye DropsJournal of Ocular Pharmacology and Therapeutics, 1992
- Reduction of Blood Glucose Concentration With Insulin Eye DropsDiabetes Care, 1988
- Treatment of Hypoglycemia with Glucagon Eye DropsJournal of Ocular Pharmacology and Therapeutics, 1988
- Structure of desacylsaponins obtained from the bark of Quillaja saponariaPhytochemistry, 1986
- Nasal absorption of insulin: enhancement by hydrophobic bile salts.Proceedings of the National Academy of Sciences, 1985
- Insulin Administered Intranasally as an Insulin-Bile Salt Aerosol: Effectiveness and Reproducibility in Normal and Diabetic SubjectsDiabetes, 1983
- Nasal Absorption of Insulin in DogsDiabetes, 1978